Download Now - The Burrill Report

More documents

Recommendations

Info

SEPTEMBER STATISTICSThe Burrill Report❱❱ (continued)September 2012 PartneringCOMPANY/LICENSERGVK Biosciences(India)COMPANY/LICENSEE DEAL TYPE TOTALPOTENTIAL DEALVALUE (USD M)NIH National CancerInstituteUPFRONTPAYMENT(USD M)ASSET PHASEPRINCIPAL FOCUSLicense N/A BiomarkerdatabaseWest Janssen Biotech (J&J) Collaboration N/A Drug deliverytechnologyScynexisBioFocus(Galapagos-Belgium)Dechra Pharmaceuticals(United Kingdom)Ono Pharmaceutical(Japan)License N/A N/A Canine eye careCollaboration N/A Discovery CNSMacroGenics ImaginAb Collaboration N/A In vivo imagingagentsBiokineTherapeuticsImprimisPharmaceuticalsSFJPharmaceuticalsStarpharmaHoldingsAniona ApS(Denmark)WuXi App Tec(China)Summit (UnitedKingdom)BioLineRx (Israel) License N/A Phase 1 HematologyProfessionalCompounding Centers ofAmericaAgreement N/A Drug formulationtechnologyPfizer Collaboration N/A Clinical drugdevelopmentAstraZeneca (UnitedKingdom)Agreement N/A OncologyNeuroSearch (Denmark) License N/A CNSAstraZeneca (UnitedKingdom)Joint Venture N/A Phase 1 Autoimmune,inflammationBristol-Myers Squibb License N/A 0.1 Discovery Technology accessVisterra Pfizer Collaboration N/A N/A Discovery AntibodiesIllumina Partners HealthCare Alliance N/A Genomic analysisVascularPharmaceuticalsHelsinn Group(Switzerland)Harbour Antibodies(Netherlands)Sinclair IS Pharma(United Kingdom)Janssen Biotech (J&J) License N/A N/A Preclinical DiabeticnephropathyDARA Biosciences License N/A Marketed Oral mucositisShangPharma (China) License N/A AntibodiesQuintilesLicense/collaborationN/A Marketed Emerging marketsGA2LEN (Germany) PPD Alliance N/A AllergiesVical Bristol-Myers Squibb License N/A Vaccine platformlicenseTrovagene Quest Diagnostics License N/A Cancer biomarkerOasmiaPharmaceutical(Sweden)Pharmasyntez (Russia) MOU N/A Drug deliveryLife Technologies Bristol-Myers Squibb Partnership N/A Companion DxJouleAudi (Volkswagen-Germany)Partnership N/A BiofuelsWalmart Humana Partnership N/A WellnessGNS Healthcare Covance Collaboration N/A Drug developmentAvidBiotics DuPont Collaboration N/A Food safety(continued) ❱❱November 2012 36
SEPTEMBER STATISTICSThe Burrill Report❱❱ (continued)September 2012 PartneringCOMPANY/LICENSERCOMPANY/LICENSEE DEAL TYPE TOTALPOTENTIAL DEALVALUE (USD M)UPFRONTPAYMENT(USD M)ASSET PHASEDyax Kadmon License N/A Preclinical CancerCuretis (Germany)Heraeus Medical(Germany)PRINCIPAL FOCUSCollaboration N/A Medical deviceCytokinetics MyoKardia Collaboration N/A CardiovascularGeneNews(Canada)Royal PhilipsElectronics(Netherlands)Helsinn Group(Switzerland)ULURUShanghai Biochip (China) Alliance N/A PersonalizedmedicineThe Oncology Group;Revenue CycleCJ CheilJedang (SouthKorea)Melmed Holding(Germany)Alliance N/A Integrated cancercareLicense N/A Cancer side effectsLicense N/A Wound careLamdaGen Biodico Collaboration N/A BiorenewablesGalaxy Biotech Roche (Switzerland) License N/A 8 Preclinical CancerGNS Healthcare Aetna Partnership N/A MetabolicsyndromePulmagen (UnitedKingdom)Roche Diagnostics(Switzerland)PeptiDream (Japan)Teijin Pharma (Japan) License N/A Phase 2 AsthmaAstraZeneca (UnitedKingdom)GlaxoSmithKline (UnitedKingdom)Partnership N/A CompaniondiagnosticsPartnership N/A Discovery PeptidetherapeuticsOlympus (Japan) Sony (Japan) Joint venture N/A Medical devicesMBC PharmaOsteros Biomedica(Russia)License N/A Preclinical Cancer,musculoskeletalnCompany/Academic/Non-Profit Partnerships in September 2012COMPANY COUNTRY ACADEMIA/NON-PROFIT COUNTRY PRINCIPAL FOCUSTransgenomic United States NYU-Langone Medical Center United States Cancer research collaborationAstex Pharmaceuticals United States Cancer Research Technology United Kingdom Epigenetic drug discoverycollaborationAstraZeneca United States Broad Institute United States Infectious disease drug discoverycollaboration10 Top Biopharmas Global TransCelerate BioPharma United States Solving R&D challengesSanofi France Global Alliance for TB Drug Development Global TB drug development collaborationBioPontis Alliance United States University of Massachusetts Medical School United States Drug discovery partnershipBristol-Myers Squibb United States Vanderbilt University United States Parkinson’s therapiesnNovember 2012 37
Page 2 and 3: The Burrill ReportThe Burrill Repor
Page 5: The Burrill ReportThe Risk and Rewa
Page 10 and 11: The Burrill ReportTHIRD QUARTER STA
Page 12 and 13: THIRD QUARTER STATISTICSThe Burrill
Page 24 and 25: SEPTEMBER STATISTICSThe Burrill Rep
Page 28: SEPTEMBER STATISTICSThe Burrill Rep
Page 39 and 40: PIPELINEThe Burrill Report❱❱ (c
Page 45: PIPELINEThe Burrill Report❱❱ (c
Page 48 and 49: PIPELINEThe Burrill ReportUpcoming
Page 50 and 51: INDICESThe Burrill ReportBurrill Bi

Download Now - The Burrill Report

Create successful ePaper yourself

Delete template?

Save as template?